Research interests Workgroups

• IP4 - Head and neck
• WP1 - Biomarkers (molecular and imaging)

Publications

• Offersen BV, Alsner J, Nielsen HM, Jakobsen EH, Nielsen MH, Krause M, Stenbygaard L, Mjaaland I, Schreiber A, Kasti UM, Overgaard J Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial J Clin Oncol. 2020 Nov 1;38(31):3615-3625 2020
• Offersen BV, Overgaard J Breast cancer radiation therapy Lancet . 2020 Nov 14;396(10262):1558 2020
• Elming PB, Sørensen BS, Spejlborg H, Overgaard J, Horsman MR Does the combination of hyperthermia with low LET (linear energy transfer) radiation induce anti-tumor effects equivalent to those seen with high LET radiation alone? Int J Hyperthermia . 2021;38(1):105-110 2021
• Lassen P, Schou M, Overgaard J, Alsner J Correlation and prognostic impact of human papilloma virus and p16-expression in advanced hypopharynx and larynx cancer treated with definitive radiotherapy Acta Oncol . 2021 May;60(5):646-648 2021
• Kjems J, Zukauskaite R, Johansen J, Eriksen JG, Lassen P, Andersen E, Andersen M, Farhadi M, Overgaard J, Vogelius IR, Friborg J Distant metastases in squamous cell carcinoma of the pharynx and larynx: a population-based DAHANCA study Acta Oncol. 2021 Nov;60(11):1472-1480 2021
• Alsner J, Overgaard J, Tramm T, Lindegaard JC Hypoxic gene expression is a prognostic factor for disease free survival in a cohort of locally advanced squamous cell cancer of the uterine cervix Acta Oncol . 2022 Feb;61(2):172-178 2022
• Tramm T, Vinter H, Vahl P, Özcan D, Alsner J, Overgaard J Tumor-infiltrating lymphocytes predict improved overall survival after post-mastectomy radiotherapy: a study of the randomized DBCG82bc cohort Acta Oncol . 2022 Feb;61(2):153-162 2022
• Høyer M, Grau C, Overgaard J No time to die - BiGART is back. The 20th Acta Oncologica Symposium - BIGART 2021 Acta Oncol . 2022 Feb;61(2):117-119 2022
• Schack LMH, Naderi E, Fachal L, Dorling L, Luccarini C, Dunning AM; Head and Neck Group of the Radiogenomics Consortium; Danish Head and Neck Cancer Group (DAHANCA), Ong EHW, Chua MLK, Langendijk JA, Alizadeh BZ, Overgaard J, Eriksen JG, Andreassen CN, Alsner J A genome-wide association study of radiotherapy induced toxicity in head and neck cancer patients identifies a susceptibility locus associated with mucositis Br J Cancer . 2022 Apr;126(7):1082-1090 2022
• Overgaard J, Aznar MC, Bacchus C, Coppes RP, Deutsch E, Georg D, Haustermans K, Hoskin P, Krause M, Lartigau EF, Lee AWM, Löck S, Offersen BV, Thwaites DI, van der Kogel AJ, van der Heide UA, Valentini V, Baumann M Personalised radiation therapy taking both the tumour and patient into consideration Radiother Oncol . 2022 Jan;166:A1-A5 2022
• Overgaard M, Nielsen HM, Tramm T, Højris I, Grantzau TL, Alsner J, Offersen BV, Overgaard J; DBCG Radiotherapy Group Postmastectomy radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. A 30-year long-term report from the Danish breast cancer cooperative group DBCG 82bc trial Radiother Oncol . 2022 May;170:4-13 2022
• Thorsen LBJ, Overgaard J, Matthiessen LW, Berg M, Stenbygaard L, Pedersen AN, Nielsen MH, Overgaard M, Offersen BV Internal Mammary Node Irradiation in Patients With Node-Positive Early Breast Cancer: Fifteen-Year Results From the Danish Breast Cancer Group Internal Mammary Node Study J Clin Oncol . 2022 Apr 8 2022
• Lefèvre AC, Alsner J, Sørensen BS, Tramm T, Toustrup K, Overgaard J, Spindler KG Hypoxia and local tumour control in squamous cell carcinoma of the anus - a hypothesis-generating study Acta Oncol . 2022 Jun 22;1-4 2022
• Offersen BV, Alsner J, Nielsen HM, Jakobsen EH, Nielsen MH, Stenbygaard L, Pedersen AN, Thomsen MS, Yates E, Berg M, Lorenzen EL, Jensen I, Josipovic M, Jensen MB, Overgaard J; Danish Breast Cancer Group Radiotherapy Committee Partial Breast Irradiation Versus Whole Breast Irradiation for Early Breast Cancer Patients in a Randomized Phase III Trial: The Danish Breast Cancer Group Partial Breast Irradiation Trial J Clin Oncol . 2022 Aug 5 2022
• Lassen P, Huang SH, Su J, Waldron J, Andersen M, Primdahl H, Johansen J, Kristensen CA, Andersen E, Eriksen JG, Hansen CR, Alsner J, Lilja-Fisher J, Bratman SV, Ringash J, Kim J, Hope A, Spreafico A, de Almeida J, Xu W, O'Sullivan B, Overgaard J Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts Int J Cancer . 2022 Apr 15;150(8):1329-1340 2022
• Sharma MB, Jensen K, Friborg J, Smulders B, Andersen E, Samsøe E, Johansen J, Hansen CR, Andersen M, Nielsen MS, Filtenborg MV, Ren J, Korreman SS, Overgaard J, Grau C Target coverage and local recurrences after radiotherapy for sinonasal cancer in Denmark 2008-2015. A DAHANCA study Acta Oncol . 2022 Feb;61(2):120-126 2022
• Kristian Hastoft Jensen Ivan Vogelius, Claus Ernst Moser , Elo Andersen, Jesper Grau Eriksen, Jørgen Johansen , Mohammad Farhadi, Maria Andersen, Jens Overgaard, Jeppe Friborg Bloodstream infections in head and neck cancer patients after curative-intent radiotherapy: a population-based study from the Danish Head and Neck Cancer Group database Br J Cancer. 2021 Aug;125(3):458-464 2021
• Nijhuis H, van Rooij W, Gregoire V, Overgaard J, Slotman BJ, Verbakel WF, Dahele M. Investigating the potential of deep learning for patient-specific quality assurance of salivary gland contours using EORTC-1219-DAHANCA-29 clinical trial data Acta Oncol. 2021 Jan 11:1-7. 2021
• Aznar MC, Bacchus C, Coppes RP, Deutsch E, Georg D, Haustermans K, Hoskin P, Krause M, Lartigau EF, Löck S, Offersen B, Overgaard J, Thwaites DI, van der Kogel AJ, van der Heide UA, Valentini V, Baumann M. Radiation oncology in the new virtual and digital era Radiother Oncol. 2020 Dec 30:S0167-8140(20)31258-5. 2021
• Offersen BV, Alsner J, Nielsen HM, Jakobsen EH, Nielsen MH, Krause M, Stenbygaard L, Mjaaland I, Schreiber A, Kasti UM, Overgaard J; Danish Breast Cancer Group Radiation Therapy Committee Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial J Clin Oncol. 2020 Nov 1;38(31):3615-3625. 2020
• Busk M, Overgaard J, Horsman MR Imaging of Tumor Hypoxia for Radiotherapy: Current Status and Future Directions Semin Nucl Med. 2020 Nov;50(6):562-583. 2020
• Gregersen PA, Olsen MH, Urbak SF, Funding M, Dalton SO, Overgaard J, Alsner J Incidence and Mortality of Second Primary Cancers in Danish Patients With Retinoblastoma, 1943-2013 JAMA Netw Open. 2020 Oct 1;3(10):e2022126. 2020
• Saksø M, Primdahl H, Johansen J, Nowicka-Matus K, Overgaard J; DAHANCA DAHANCA 33: functional image-guided dose-escalated radiotherapy to patients with hypoxic squamous cell carcinoma of the head and neck (NCT02976051) Acta Oncol. 2020 Feb;59(2):208-211 2020
• Baumann M, Ebert N, Kurth I, Bacchus C, Overgaard J What will radiation oncology look like in 2050? A look at a changing professional landscape in Europe and beyond Mol Oncol. 2020 Jul;14(7):1577-1585. 2020
• Lilja-Fischer JK, Eriksen JG, Georgsen JB, Vo TT, Larsen SR, Cheng J, Busch-Sørensen M, Aurora-Garg D, Steiniche T, Overgaard J. Prognostic impact of PD-L1 in oropharyngeal cancer after primary curative radiotherapy and relation to HPV and tobacco smoking. Acta Oncol. 2020 Jun;59(6):666-672. 2020
• Jensen K, Friborg J, Hansen CR, Samsøe E, Johansen J, Andersen M, Smulders B, Andersen E, Nielsen MS, Eriksen JG, Petersen JBB, Elstrøm UV, Holm AI, Farhadi M, Morthorst MH, Skyt PS, Overgaard J, Grau C The danish head and neck cancer group (DAHANCA) 2020 radiotherapy guidelines. Radiother Oncol. 2020 Aug 8;151:149-151. 2020
• Saksø M, Mortensen LS, Primdahl H, Johansen J, Kallehauge J, Hansen CR, Overgaard J Influence of FAZA PET hypoxia and HPV-status for the outcome of head and neck squamous cell carcinoma (HNSCC) treated with radiotherapy: Long-term results from the DAHANCA 24 trial (NCT01017224). Radiother Oncol. 2020 Aug 14;151:126-133. 2020
• Jensen KH, Vogelius I, Kristensen CA, Andersen E, Overgaard J, Eriksen JG, Primdahl H, Johansen J, Farhadi M, Andersen M, Friborg J Early Mortality after Radical Radiotherapy in Head and Neck Cancer - A Nationwide Analysis from the Danish Head and Neck Cancer Group (DAHANCA) Database. Clin Oncol (R Coll Radiol) . 2020 Jul 19;S0936-6555(20)30286-7. 2020
• Lilja-Fischer JK, Ulhøi BP, Alsner J, Stougaard M, Thomsen MS, Busk M, Lassen P, Steiniche T, Nielsen VE, Overgaard J. Characterization and radiosensitivity of HPV-related oropharyngeal squamous cell carcinoma patient-derived xenografts. Acta Oncol. 2019 Oct;58(10):1489-1494. 2019
• Saksø M, Andersen E, Bentzen J, Andersen M, Johansen J, Primdahl H, Overgaard J, Eriksen JG. A prospective, multicenter DAHANCA study of hyperfractionated, accelerated radiotherapy for head and neck squamous cell carcinoma. Acta Oncol. 2019 Oct;58(10):1495-1501. 2019
• Lilja-Fischer JK, Saksø M, Stougaard M, Steiniche T, Overgaard J. Distinguishing recurrence and new primary tumor as well as the origin of neck metastases in head and neck cancer clinical trials by targeted DNA sequencing. Acta Oncol. 2019 Oct;58(10):1506-1508. 2019
• Busk M, Horsman MR, Overgaard J, Jakobsen S. Dual-tracer PET of viable tumor volume and hypoxia for identification of necrosis-containing radio-resistant Sub-volumes. Acta Oncol. 2019 Oct;58(10):1476-1482. 2019
• Andreassen CN, Eriksen JG, Jensen K, Hansen CR, Sørensen BS, Lassen P, Alsner J, Schack LMH, Overgaard J, Grau C. IMRT - Biomarkers for dose escalation, dose de-escalation and personalized medicine in radiotherapy for head and neck cancer. Oral Oncol. 2018 Nov;86:91-99. 2018
• Zukauskaite R, Hansen CR, Grau C, Samsøe E, Johansen J, Petersen JBB, Andersen E, Brink C, Overgaard J, Eriksen JG Local recurrences after curative IMRT for HNSCC: Effect of different GTV to high-dose CTV margins. Radiother Oncol. 2018 Jan;126(1):48-55. 2018
• Hansen CR, Friborg J, Jensen K, Samsøe E, Johnsen L, Zukauskaite R, Grau C, Maare C, Johansen J, Primdahl H, Bratland Å, Kristensen CA, Andersen M, Eriksen JG, Overgaard J NTCP model validation method for DAHANCA patient selection of protons versus photons in head and neck cancer radiotherapy. Acta Oncol. 2019 Oct;58(10):1410-1415. 2019
• Elming PB, Sørensen BS, Oei AL, Franken NAP, Crezee J, Overgaard J, Horsman MR Hyperthermia: The Optimal Treatment to Overcome Radiation Resistant Hypoxia. Cancers (Basel). 2019 Jan 9;11(1). 2019
• Laurberg T, Tramm T, Nielsen T, Alsner J, Nord S, Myhre S, Sørlie T, Leung S, Fan C, Perou C, Gelmon K, Overgaard J, Voduc D, Prat A, Cheang MCU Intrinsic subtypes and benefit from postmastectomy radiotherapy in node-positive premenopausal breast cancer patients who received adjuvant chemotherapy - results from two independent randomized trials. Acta Oncol. 2018 Jan;57(1):38-43 2018
• Tramm T, Kyndi M, Sørensen FB, Overgaard J, Alsner J Influence of intra-tumoral heterogeneity on the evaluation of BCL2, E-cadherin, EGFR, EMMPRIN, and Ki-67 expression in tissue microarrays from breast cancer. Acta Oncol. 2018 Jan;57(1):102-106. 2018
• Brøndum L, Alsner J, Sørensen BS, Maare C, Johansen J, Primdahl H, Evensen JF, Kristensen CA, Andersen LJ, Overgaard J, Eriksen JG Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial. Acta Oncol. 2018 Sep;57(9):1159-1164 2018
• Overgaard J, Muren LP, Høyer M, Grau C BIGART 2019 - adapting to the future. Acta Oncol. 2019 Oct;58(10):1323-1327. 2019
• Naderi E, Schack LMH, Welsh C, Sim AYL, Aguado-Barrera ME, Dudding T, Summersgil H, Martínez-Calvo L, Ong EHW, Odding Y, Varela-Pazos A, Steenbakkers RJHM, Crijns APG, Jena R, Pring M, Dennis J, Lobato-Busto R, Alsner J, Ness A, Nutting C, Thomson DJ, Gómez-Caamaño A, Eriksen JG, Thomas SJ, Bates AM, Overgaard J, Cascallar-Caneda LM, Duprez F, Barnett GC, Dorling L, Chua MLK, Vega A, West CML, Langendijk JA, Nicolaj Andreassen C, Alizadeh BZ; On the behalf of the Radiogenomics Consortium. Meta-GWAS identifies the heritability of acute radiation-induced toxicities in head and neck cancer. Radiother Oncol. 2022 Sep 30;176:138-148 2022
• Ejlertsen B, Offersen BV, Overgaard J, Christiansen P, Jensen MB, Kroman N, Knoop AS, Mouridsen H Forty years of landmark trials undertaken by the Danish Breast Cancer Cooperative Group (DBCG) nationwide or in international collaboration Acta Oncol. 2018 Jan;57(1):3-12 2018
• Jacobsen KM, Villadsen NL, Tørring T, Nielsen CB, Salomón T, Nielsen MM, Tsakos M, Sibbersen C, Scavenius C, Nielsen R, Christensen EI, Guerra PF, Bross P, Pedersen JS, Enghild JJ, Johannsen M, Frøkiær J, Overgaard J, Horsman MR, Busk M, Poulsen TB APD-Containing Cyclolipodepsipeptides Target Mitochondrial Function in Hypoxic Cancer Cells. Cell Chem Biol. 2018 Nov 15;25(11):1337-1349.e12 2018
• Lassen P, Lacas B, Pignon JP, Trotti A, Zackrisson B, Zhang Q, Overgaard J, Blanchard P; MARCH Collaborative Group Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV project. Radiother Oncol. 2018 Jan;126(1):107-115 2018
• Mäkitie A, Ruuskanen M, Bentzen J, Brun E, Gebre-Medhin M, Friesland S, Marsk E, Hammarstedt-Nordenvall L, Gille E, Reizenstein J, Adell G, Farnebo L, Rzepecki J, Haugen H, Söderström K, Zackrisson B, Bergström S, Lödén B, Cederblad L, Laurell G, Smeland E, Folkvard Evensen J, Lund JÅ, Tøndel H, Karlsdottir Å, Jóhannsson J, Johansen J, Kristensen CA, Jensen K, Andersen LJ, Koivunen P, Korpela M, Voutilainen L, Wigren T, Minn H, Joensuu H, Overgaard J, Saarilahti K The management and survival outcomes of nasopharyngeal cancer in the Nordic countries Acta Oncol. 2018 Apr;57(4):557-560. 2018
• Overgaard J, Hoff CM, Hansen HS, Specht L, Overgaard M, Lassen P, Andersen E, Johansen J, Andersen LJ, Evensen JF, Alsner J, Grau C. DAHANCA 10 - Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group. Radiother Oncol. 2018 Apr;127(1):12-19 2018
• Overgaard J RE: Hypofractionated Radiotherapy for Patients with Early-Stage Glottic Cancer: Patterns of Care and Survival. J Natl Cancer Inst. 2018 Apr 1;110(4):430-431 2018
• Evensen JF, Sand Hansen H, Overgaard M, Johansen J, Andersen LJ, Overgaard J. DAHANCA 9 - a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC) Acta Oncol. 2019 Oct;58(10):1502-1505 2019
• Hill-Madsen L, Kristensen CA, Andersen E, Johansen J, Andersen LJ, Primdahl H, Overgaard J, Lyhne NM Subglottic squamous cell carcinoma in Denmark 1971-2015 - a national population-based cohort study from DAHANCA, the Danish Head and Neck Cancer group. Acta Oncol. 2019 Oct;58(10):1509-1513 2019
• Löck S, Linge A, Seidlitz A, Bandurska-Luque A, Nowak A, Gudziol V, Buchholz F, Aust DE, Baretton GB, Zöphel K, Steinbach J, Kotzerke J, Overgaard J, Zips D, Krause M, Baumann M, Troost EGC Repeat FMISO-PET imaging weakly correlates with hypoxia-associated gene expressions for locally advanced HNSCC treated by primary radiochemotherapy. Radiother Oncol. 2019 Jun;135:43-50 2019
• Overgaard J, Alsner J Effect of ESA as a modifier of radiotherapy in curative intended treatment of squamous cell carcinoma of the head and neck (HNSCC) Radiother Oncol. 2019 Jan;130:191-192 2019
• Tol JP, Dahele M, Gregoire V, Overgaard J, Slotman BJ, Verbakel WFAR Analysis of EORTC-1219-DAHANCA-29 trial plans demonstrates the potential of knowledge-based planning to provide patient-specific treatment plan quality assurance Radiother Oncol. 2019 Jan;130:75-81 2019
• Baumann M, Ebert N, Kurth I, Bacchus C, Overgaard J What will radiation oncology look like in 2050? A look at a changing professional landscape in Europe and beyond Mol Oncol. 2020 Jul;14(7):1577-1585 2020
• Baumann M, Overgaard J, Bacchus C. Radiotherapy & Oncology during the COVID-19 pandemic. Radiotherapy & Oncology during the COVID-19 pandemic Radiother Oncol. 2020 May;146:221-222. 2020
• Deschuymer S, Sørensen BS, Dok R, Laenen A, Hauben E, Overgaard J, Nuyts S Prognostic value of a 15-gene hypoxia classifier in oropharyngeal cancer treated with accelerated chemoradiotherapy Strahlenther Onkol. 2020 Jun;196(6):552-560 2020
• Overgaard J, Baumann M Four decades with ESTRO Radiother Oncol. 2020 Jan;142:1-5 2020
• Saksø M, Jensen K, Andersen M, Hansen CR, Eriksen JG, Overgaard J. DAHANCA 28: A phase I/II feasibility study of hyperfractionated, accelerated radiotherapy with concomitant cisplatin and nimorazole (HART-CN) for patients with locally advanced, HPV/p16-negative squamous cell carcinoma of the oropharynx, hypopharynx, larynx and oral cavity Radiother Oncol. 2020 Jul;148:65-72 2020
• Zakeri K, Rotolo F, Lacas B, Vitzthum LK, Le QT, Gregoire V, Overgaard J, Hackshaw A, Zackrisson B, Parmar MKB, Burtness BA, Ghi MG, Sanguineti G, O'Sullivan B, Fortpied C, Bourhis J, Shen H, Harris J, Michiels S, Pignon JP, Mell LK; MARCH/MACH-NC Collaborative Group and the Head and Neck Cancer Intergroup Predictive classifier for intensive treatment of head and neck cancer Cancer. 2020 Dec 15;126(24):5263-5273 2020
• Zschaeck S, Löck S, Hofheinz F, Zips D, Saksø Mortensen L, Zöphel K, Troost EGC, Boeke S, Saksø M, Mönnich D, Seidlitz A, Johansen J, Skripcak T, Gregoire V, Overgaard J, Baumann M, Krause M. Individual patient data meta-analysis of FMISO and FAZA hypoxia PET scans from head and neck cancer patients undergoing definitive radio-chemotherapy Radiother Oncol. 2020 Aug;149:189-196 2020
• Eriksen JG, Johansen J, Godballe C, Kjærgaard T, Primdahl H, Charabi B, Andersen E, Farhadi M, Kristensen CA, Lyhne N, Andersen M, Grau C, Høyrup M, Hvass SA, Overgaard J Danish Head & Neck Cancer group (DAHANCA) kvalitetsdatabase - Resumé af årsrapport 2020 Ugeskr Læg 2021. 2021
• Filtenborg MV, Lilja-Fischer JK, Sharma MB, Primdahl H, Kjems J, Plaschke CC, Wessel I, Kristensen CA, Andersen M, Andersen E, Godballe C, Johansen J, Overgaard J, Petersen KB Sinonasal cancer in Denmark 2008-2015: a population-based phase-4 cohort study from DAHANCA Acta Oncol. 2021 Mar;60(3):333-342 2021
• Gregersen PA, Funding M, Alsner J, Olsen MH, Overgaard J, Urbak SF, Staffieri SE, Lou S Living with heritable retinoblastoma and the perceived role of regular follow-up at a retinoblastoma survivorship clinic: 'That is exactly what I have been missing' BMJ Open Ophthalmol. 2021 Sep 12;6(1):e000760 2021
• Nijhuis H, van Rooij W, Gregoire V, Overgaard J, Slotman BJ, Verbakel WF, Dahele M Investigating the potential of deep learning for patient-specific quality assurance of salivary gland contours using EORTC-1219-DAHANCA-29 clinical trial data Acta Oncol. 2021 May;60(5):575-581 2021
• Petit C, Lacas B, Pignon JP, Le QT, Grégoire V, Grau C, Hackshaw A, Zackrisson B, Parmar MKB, Lee JW, Ghi MG, Sanguineti G, Temam S, Cheugoua-Zanetsie M, O'Sullivan B, Posner MR, Vokes EE, Cruz Hernandez JJ, Szutkowski Z, Lartigau E, Budach V, Suwiński R, Poulsen M, Kumar S, Ghosh Laskar S, Mazeron JJ, Jeremic B, Simes J, Zhong LP, Overgaard J, Fortpied C, Torres-Saavedra P, Bourhis J, Aupérin A, Blanchard P; MACH-NC and MARCH Collaborative Groups Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis Lancet Oncol. 2021 May;22(5):727-736 2021
• Sharabiani M, Clementel E, Andratschke N, Collette L, Fortpied C, Grégoire V, Overgaard J, Willmann J, Hurkmans C Independent external validation using the EORTC HNCG-ROG 1219 DAHANCA 29 trial data of NTCP models for acute oral mucositis Radiother Oncol. 161: 35-39, 2021 2021
• Thomsen MS, Alsner J, Nielsen HM, Jakobsen EH, Nielsen MH, Møller M, Pedersen AN, Yates E, Berg M, Lorenzen E, Jensen I, Josipovic M, Overgaard J, Offersen BV; DBCG RT Committee Volume matters: Breast induration is associated with irradiated breast volume in the Danish Breast Cancer Group phase III randomized Partial Breast Irradiation trial Radiother Oncol. 2022 Dec;177:231-235 2022
• Olsen MH, Frederiksen K, Lassen P, Rotbøl C, Kjaer TK, Johansen J, Primdahl H, Andersen E, Kristensen CA, Andersen M, Farhadi M, Overgaard J, Dalton SO; Danish Head and Neck Cancer Group (DAHANCA) Association of Smoking, Comorbidity, Clinical Stage, and Treatment Intent With Socioeconomic Differences in Survival After Oropharyngeal Squamous Cell Carcinoma in Denmark JAMA Netw Open. 2022 Dec 1;5(12):e2245510 2022
• Offersen BV, Overgaard M, Overgaard J. Breast cancer radiotherapy: Is it time to rethink the indication? Radiother Oncol. 2022 Dec;177:238-239 2022
• Kok HP, van Rhoon GC, Herrera TD, Overgaard J, Crezee J Biological modeling in thermoradiotherapy: present status and ongoing developments toward routine clinical use Int J Hyperthermia. 2022;39(1):1126-1140 2022
• Gregersen PA, Funding M, Alsner J, Olsen MH, Overgaard J, Staffieri SE, Lou S, Urbak SF Genetic testing in adult survivors of retinoblastoma in Denmark: A study of the experience and impact of genetic testing many years after initial diagnosis Eur J Med Genet. 2022 Sep;65(9):104569 2022
• Forner LE, Dieleman FJ, Shaw RJ, Kanatas A, Butterworth CJ, Kjeller G, Alsner J, Overgaard J, Hillerup S, Hyldegaard O, Arnell P, von Buchwald C, Kaanders JHAM, Smeele LE, Specht L, Johansen J, Witjes MJH, Merkx MAW, Jansen EC Hyperbaric oxygen treatment of mandibular osteoradionecrosis: Combined data from the two randomized clinical trials DAHANCA-21 and NWHHT2009-1. Radiother Oncol. 2022 Jan;166:137-144 2022
• Filtenborg MV, Lilja-Fischer JK, Sharma MB, Primdahl H, Kjems J, Plaschke CC, Charabi BW, Kristensen CA, Andersen M, Andersen E, Godballe C, Johansen J, Overgaard J, Petersen KB Nasal vestibule squamous cell carcinoma: a population-based cohort study from DAHANCA Acta Oncol. 2022 Feb;61(2):127-133 2022